联合吸入布地奈德混悬液和特布他林雾化液治疗婴幼儿哮喘的疗效

目的探讨联合吸入布地奈德混悬液和特布他林雾化液治疗婴幼儿哮喘的疗效及安全性。方法对75例哮喘婴幼儿采用双盲对照随机抽样法,设单纯吸入特布他林雾化液（A组）及联合吸入布地奈德混悬液和特布他林雾化液（B组）、单纯吸入布地奈德混悬液（C组）3组分别进行治疗,每组25例。观察比较3组疗效及安全性。结果A组治愈16例,显效3例,无效6例,总有效率76%;B组治愈22例,显效2例,无效1例,总有效率96%;C组治愈14例,显效4例,无效7例,总有效率72%。A、B组总有效率比较有显著性差异（P〈0.05）;B、C组总有效率比较有显著性差异（P〈0.05）;A、C组总有效率比较差异无显著性（P〉0.05）。结论联合吸入布地奈德混悬液和特布他林雾化液治疗婴幼儿哮喘疗效优于单纯吸入特布他林雾化液和单纯吸入布地奈德混悬液,不良反应少,安全性好。

Curative Effects of Budesonide Suspension Combined with Ubertaline Solution for Nebulization on Infantile Asthma

Objective To study the clinic effects and safety of budesonide suspension combined with tubertaline solution for nebulization therapy on infantile asthma.Methods Seventy-five cases with asthma were divided into 3 groups randomly,double-blinded and controlled,each group having 25 cases.Group A inhaling tubertaline solution(bricanyl),while group B inhaling pulmicort respules combined with bricanyl,group C inhaling budesonide suspension(pulmicort respules)only.Results In group A,16 cases was cure,3 cases was markedly improved,6 cases was failure,the total efficacy rate was 76 percent.In group B,22 cases was cure,2 cases was markedly improved,1 case failed,the total efficacy rate was 96 percent.While in group C,14 cases was cure,4 cases was markedly improved,7 cases failed,the total efficacy rate was 72 percent.The difference of efficacy rate between group A and group B was significant(P<0.05),the difference between group C and group B was also significant(P<0.05),while the difference between group A and group C was not significant(P>0.05).Conclusion Pulmicort respules combined with bricanyl for nebulising inhalation is effective and safety on infantile asthma and its effect is better than inhaling bude-sonide or tubertaline only.